A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Who We Are We are a leading home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. We have a differentiated approach to care delivery, with an integrated and scaled model that addresses critical services that the highest-need and highest-cost patients require. With a focus on Senior and Specialty patients, which includes Behavioral populations, our platform provides pharmacy and provider services (both clinical and supportive care in nature) in lower-cost home and community settings largely to Medicare, Medicaid, and commercially-insured populations. We are an essential part of our nation’s health delivery network as a front-line provider of high-quality and cost-effective care to a large and growing number of people, who increasingly require a combination of specialized solutions to enable holistic health care management.
| Metric | TTM | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenue | 12.9B | 12.9B | 10.1B | 7.7B | 7.7B |
| Net Income | 191M | 191M | -18M | -155M | -54M |
| EPS | $0.87 | $0.87 | $-0.09 | $-1.31 | $-0.46 |
| Free Cash Flow | 395M | 395M | -57M | 137M | -75M |
| ROIC | 5.6% | 5.2% | 2.6% | 2.3% | - |
| Gross Margin | 11.8% | 11.8% | 12.6% | 14.8% | 17.5% |
| Debt/Equity | 1.43 | 1.43 | 1.69 | 6.22 | - |
| Dividends/Share | $0.00 | - | - | - | - |
| Operating Income | 295M | 295M | 108M | 58M | 188M |
| Operating Margin | 2.3% | 2.3% | 1.1% | 0.8% | 2.4% |
| ROE | 10.2% | 10.8% | -1.6% | -23.1% | - |
| Shares Outstanding | 219M | 219M | 201M | 118M | 117M |
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 7.7B | 7.7B | 10.1B | 12.9B | 12.9B |
| Gross Margin | 17.5% | 14.8% | 12.6% | 11.8% | 11.8% |
| R&D | N/A | N/A | N/A | N/A | N/A |
| SG&A | 1.1B | 1.1B | 1.2B | 1.2B | 1.2B |
| EBIT | 188M | 58M | 108M | 295M | 295M |
| Op. Margin | 2.4% | 0.8% | 1.1% | 2.3% | 2.3% |
| Net Income | -54M | -155M | -18M | 191M | 191M |
| Net Margin | -0.7% | -2.0% | -0.2% | 1.5% | 1.5% |
| Non-Recurring | 42M | -349K | -101K | -2.1M | -2.1M |
| Returns on Capital | |||||
| ROIC | N/A | 2.3% | 2.6% | 5.2% | 5.6% |
| ROE | N/A | -23.1% | -1.6% | 10.8% | 10.2% |
| ROA | N/A | -5.5% | -0.3% | 3.1% | 3.0% |
| Cash Flow | |||||
| Op. Cash Flow | -4.7M | 211M | 24M | 490M | 490M |
| Free Cash Flow | -75M | 137M | -57M | 395M | 395M |
| Owner Earnings | -212M | -161M | -385M | 15M | 15M |
| CapEx | 70M | 74M | 81M | 95M | 95M |
| Maint. CapEx | 204M | 368M | 340M | 405M | 405M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 |
| D&A | 204M | 368M | 340M | 405M | 405M |
| CapEx/OCF | N/A | N/A | 340.3% | 19.5% | 19.5% |
| Capital Allocation | |||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 650K | 650K | 43M | 43M |
| Buyback Yield | N/A | N/A | 0.0% | 0.5% | 0.4% |
| Stock-Based Comp | 3.5M | 3.9M | 69M | 70M | 70M |
| Debt Repayment | 41M | 30M | 3.4B | 50M | 50M |
| Balance Sheet | |||||
| Net Debt | 27M | 3.6B | 2.7B | 2.6B | 2.6B |
| Cash & Equiv. | 14M | 13M | 61M | 88M | 88M |
| Long-Term Debt | 41M | 3.3B | 2.6B | 2.5B | 2.5B |
| Debt/Equity | N/A | 6.22 | 1.69 | 1.43 | 1.43 |
| Interest Coverage | 0.8 | 0.2 | 0.6 | 1.9 | 1.9 |
| Equity | N/A | 585M | 1.6B | 1.9B | 1.9B |
| Total Assets | N/A | 5.5B | 5.9B | 6.4B | 6.4B |
| Total Liabilities | N/A | 4.9B | 4.3B | 4.5B | 4.5B |
| Intangibles | N/A | 881M | 595M | 558M | 558M |
| Retained Earnings | N/A | -200M | -222M | -75M | -75M |
| Working Capital | N/A | 208M | 465M | 1.0B | 1.0B |
| Current Assets | N/A | 1.5B | 1.9B | 2.9B | 2.9B |
| Current Liabilities | N/A | 1.2B | 1.4B | 1.8B | 1.8B |
| Per Share Data | |||||
| EPS | -0.46 | -1.31 | -0.09 | 0.87 | 0.87 |
| Owner EPS | -1.81 | -1.37 | -1.92 | 0.07 | 0.07 |
| Book Value | N/A | 4.95 | 8.21 | 8.56 | 8.56 |
| Cash Flow/Share | -0.04 | 1.79 | 0.12 | 2.24 | 2.72 |
| Dividends/Share | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 117.2M | 118.0M | 200.7M | 219.2M | 219.2M |
| Valuation | |||||
| P/E Ratio | N/A | N/A | N/A | 43.4 | 52.9 |
| P/FCF | N/A | N/A | N/A | 21.0 | 25.6 |
| EV/EBIT | N/A | N/A | 54.7 | 35.9 | 43.0 |
| Price/Book | N/A | N/A | 2.1 | 4.4 | 5.4 |
| Price/Sales | N/A | N/A | 0.3 | 0.4 | 0.8 |
| FCF Yield | N/A | N/A | -1.7% | 4.8% | 3.9% |
| Market Cap | N/A | N/A | 3.4B | 8.3B | 10.1B |
| Avg. Price | N/A | N/A | 12.89 | 24.20 | 46.03 |
| Year-End Price | N/A | N/A | 17.02 | 37.75 | 46.03 |
BrightSpring Health Services, Inc. passes 2 of 9 quality checks, indicating weak fundamentals.
BrightSpring Health Services, Inc. trades at 52.9x trailing earnings, compared to its 15-year median P/E of 43.4x, suggesting it is currently Expensive relative to its historical range. On a free-cash-flow basis, the stock trades at 22.6x vs a median of 21.0x. The company's 5-year average ROIC is 3.4% with a gross margin of 14.2%. Total shareholder yield (buybacks) is 0.4%. At current prices, the estimated annualized return to fair value is +22.5%.
BrightSpring Health Services, Inc. (BTSG) has a current P/E ratio of 52.9, compared to its historical median P/E of 43.4. The stock is currently considered Expensive based on its historical valuation range.
BrightSpring Health Services, Inc. (BTSG) has a 5-year average return on invested capital (ROIC) of 3.4%. This is below average and may indicate limited pricing power.
BrightSpring Health Services, Inc. (BTSG) has a market capitalization of $10.1B. It is classified as a large-cap stock.
BrightSpring Health Services, Inc. (BTSG) does not currently pay a regular dividend. However, the company returns capital to shareholders through share buybacks, with a buyback yield of 0.43%.
Based on historical P/E analysis, BrightSpring Health Services, Inc. (BTSG) appears expensive. The current P/E of 52.9 is 22% above its historical median of 43.4.
BrightSpring Health Services, Inc. (BTSG) operates in the Services-Home Health Care Services industry, within the Healthcare sector.
BrightSpring Health Services, Inc. (BTSG) reported annual revenue of $12.9 billion in its most recent fiscal year, based on SEC EDGAR filings.
BrightSpring Health Services, Inc. (BTSG) has a net profit margin of 1.5%. This is a modest margin.
BrightSpring Health Services, Inc. (BTSG) generated $395 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
BrightSpring Health Services, Inc. (BTSG) has a debt-to-equity ratio of 1.43. This indicates moderate leverage.
BrightSpring Health Services, Inc. (BTSG) reported earnings per share (EPS) of $0.87 in its most recent fiscal year.
BrightSpring Health Services, Inc. (BTSG) has a return on equity (ROE) of 10.8%. This indicates moderate shareholder returns.
BrightSpring Health Services, Inc. (BTSG) has a 5-year average gross margin of 14.2%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 4 years of financial data for BrightSpring Health Services, Inc. (BTSG), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
BrightSpring Health Services, Inc. (BTSG) has a book value per share of $8.56, based on its most recent annual SEC filing.